ストックスクリーナーアプリを入手
3.53
1.94%
-0.07
アフターアワーズ：
3.60
0.07
+1.98%
前日終値:
$3.60
開ける：
$3.5285
24時間の取引高:
1,935
Relative Volume:
0.04
時価総額：
$8.99M
収益：
$5.51M
当期純損益:
$-6.16M
株価収益率:
-9.5405
EPS:
-0.37
ネットキャッシュフロー:
$-5.03M
1週間 パフォーマンス:
+12.06%
1か月 パフォーマンス:
+16.50%
6か月 パフォーマンス:
-26.69%
1年 パフォーマンス:
+29.78%
1日の値動き範囲:
$3.5285
$3.60
1週間の範囲:
$3.09
$3.67
52週間の値動き範囲:
$1.932
$10.16
Biomerica Inc Stock (BMRA) Company Profile
BMRA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
BMRA
Biomerica Inc
|
3.53 | 9.16M | 5.51M | -6.16M | -5.03M | -0.37 |
|
ABT
Abbott Laboratories
|
125.83 | 218.75B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
107.76 | 152.62B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
400.93 | 151.01B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
92.01 | 117.43B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
76.91 | 44.76B | 5.54B | 4.18B | 623.10M | 7.00 |
Biomerica Inc Stock (BMRA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2020-11-10 | 開始されました | Colliers Securities | Buy |
| 2018-01-04 | 開始されました | B. Riley FBR, Inc. | Buy |
Biomerica Inc (BMRA) 最新ニュース
Biomerica Inc. Stock Analysis and ForecastExceptional growth trajectory - Autocar Professional
What analysts say about Biomerica Inc. stockFast-track wealth growth - Autocar Professional
Is Biomerica Inc. a good long term investmentTremendous gains - jammulinksnews.com
What drives Biomerica Inc. stock priceFree High-Return Strategy Alerts - jammulinksnews.com
Published on: 2025-07-20 03:50:26 - jammulinksnews.com
Is Biomerica Inc. stock overhyped or has real potentialFree Investment Community - Newser
How Biomerica Inc. stock performs during market volatilityTrend Based Entry Alerts - Newser
What makes Biomerica Inc. stock price move sharplyFree Investing Community - Newser
Why Biomerica Inc. stock attracts strong analyst attentionFree Stock Market Forums - Newser
Breakthrough IBS Test Secures Major Insurance Milestone: What This Means for 45M American Patients - Stock Titan
Biomerica, Inc. Secures PLA Code for inFoods® IBS Test to Enhance Patient Access and Insurance Reimbursement - Nasdaq
Biomerica Inc. Appoints Scott Madel as Chief Commercial Officer to Drive Growth of inFoods® IBS - Quiver Quantitative
Diagnostics Leader Who Drove $100M Revenue Growth Joins Biomerica to Scale IBS Testing Innovation - Stock Titan
Is Biomerica, Inc. technically bullish or bearish? - MarketsMojo
Short Interest in Biomerica, Inc. (NASDAQ:BMRA) Rises By 26.4% - Defense World
Biomerica (NASDAQ:BMRA) Stock Price Passes Below 200 Day Moving Average – What’s Next? - Defense World
Biomerica appoints Eric B. Chin to Board of Directors By Investing.com - Investing.com South Africa
Biomerica, Inc. Announces Board and Committee Changes, Effective June 4, 2025 - marketscreener.com
Biomerica appoints Eric B. Chin to Board of Directors - Investing.com Australia
Biomerica Appoints Eric B. Chin to Board - TipRanks
Biomerica Appoints Eric B. Chin to Board of Directors and Audit Committee Chair | BMRA Stock News - GuruFocus
Healthcare CFO Who Raised $60M Joins Biomerica Board to Lead Audit Committee - Stock Titan
Biomerica's inFoods IBS Clinical Study Results Published in June 2025 Issue of Gastroenterology - marketscreener.com
inFoods IBS test shows promise for IBS management - Investing.com
Biomerica (BMRA) Showcases Promising Results for inFoods IBS Tes - GuruFocus
Biomerica announces publication of data from inFoods IBS clinical study - TipRanks
Biomerica's inFoods® IBS Clinical Study Results Published in Jun - GuruFocus
Biomerica (BMRA) Showcases Promising Results for inFoods IBS Test in Clinical Trial | BMRA Stock News - GuruFocus
Biomerica's inFoods® IBS Clinical Study Results Published in June Issue of Gastroenterology - The Manila Times
Biomerica's inFoods® IBS Clinical Study Results Published in June Issue of Gastroenterology | BMRA Stock News - GuruFocus
Breakthrough IBS Treatment Shows 60% Success Rate in Major Clinical Trial, Published in Gastroenterology - Stock Titan
Biomerica announces real-world results of its inFoods IBS product - TipRanks
Biomerica (BMRA) Reports Positive Real-World Results for inFoods - GuruFocus
Biomerica Reports Real-World Data Showing 49% Reduction in IBS Symptoms with inFoods® IBS using a First of Its Kind Real-Time IBS Patient Feedback System | BMRA Stock News - GuruFocus
Wall Street Backs Dell’s AI Strategy with Buy Ratings - The Globe and Mail
New IBS Treatment Cuts Pain by 49% Without Drugs: Groundbreaking Real-Time Patient Monitoring System Launches - Stock Titan
Biomerica Inc (BMRA) 財務データ
収益
当期純利益
現金流量
EPS
0.39%
大文字化:
|
ボリューム (24 時間):